These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

810 related items for PubMed ID: 36640225

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma.
    Huang Y, Gong P, Su L, Zhang M.
    Sci Rep; 2023 Nov 27; 13(1):20870. PubMed ID: 38012210
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prognostic signature construction and immunotherapy response analysis for Uterine Corpus Endometrial Carcinoma based on cuproptosis-related lncRNAs.
    Zhang X, Ye Z, Xiao G, He T.
    Comput Biol Med; 2023 Jun 27; 159():106905. PubMed ID: 37060773
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Construction of prognostic risk model of bladder cancer based on cuproptosis-related long non-coding RNAs.
    Xu C, Chen A, Mao C, Cui B.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Apr 25; 52(2):139-147. PubMed ID: 37283097
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J, Qin D, Tao Z, Wang B, Xie Y, Wang Y, Li B, Cao J, Qiao X, Zhong S, Hu X.
    Front Immunol; 2022 Apr 25; 13():1056932. PubMed ID: 36479114
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma.
    Zhu S, Li H, Fan Y, Tang C.
    BMC Urol; 2023 Jul 21; 23(1):124. PubMed ID: 37479989
    [Abstract] [Full Text] [Related]

  • 12. Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma.
    Xu S, Liu D, Chang T, Wen X, Ma S, Sun G, Wang L, Chen S, Xu Y, Zhang H.
    Front Genet; 2022 Jul 21; 13():938259. PubMed ID: 35910212
    [Abstract] [Full Text] [Related]

  • 13. A novel cuproptosis-related lncRNA signature predicts the prognosis and immunotherapy for hepatocellular carcinoma.
    Liu Y, Jiang J.
    Cancer Biomark; 2023 Jul 21; 37(1):13-26. PubMed ID: 37005878
    [Abstract] [Full Text] [Related]

  • 14. In Silico Identification and Validation of Cuproptosis-Related LncRNA Signature as a Novel Prognostic Model and Immune Function Analysis in Colon Adenocarcinoma.
    Wang Y, Huang X, Chen S, Jiang H, Rao H, Lu L, Wen F, Pei J.
    Curr Oncol; 2022 Sep 15; 29(9):6573-6593. PubMed ID: 36135086
    [Abstract] [Full Text] [Related]

  • 15. A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer.
    Bai Y, Zhang Q, Liu F, Quan J.
    Front Immunol; 2022 Sep 15; 13():1027449. PubMed ID: 36451815
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A cuproptosis-related long non-coding RNA signature to predict the prognosis and immune microenvironment characterization for lung adenocarcinoma.
    Ma S, Zhu J, Wang M, Zhu J, Wang W, Xiong Y, Jiang R, Seetharamu N, Abrão FC, Puthamohan VM, Liu L, Jiang T.
    Transl Lung Cancer Res; 2022 Oct 15; 11(10):2079-2093. PubMed ID: 36386454
    [Abstract] [Full Text] [Related]

  • 18. Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia.
    Zhu Y, He J, Li Z, Yang W.
    BMC Bioinformatics; 2023 Feb 03; 24(1):37. PubMed ID: 36737692
    [Abstract] [Full Text] [Related]

  • 19. A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer.
    Ren L, Yang X, Wang W, Lin H, Huang G, Liu Z, Pan J, Mao X.
    Front Genet; 2023 Feb 03; 14():1096783. PubMed ID: 36911392
    [Abstract] [Full Text] [Related]

  • 20. Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma.
    Liu B, Liu Z, Feng C, Li C, Zhang H, Li Z, Tu C, He S.
    Front Endocrinol (Lausanne); 2022 Feb 03; 13():987942. PubMed ID: 36313774
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.